Find clinical trials for Melanoma in Miami, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Miami, FL, USA:
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
Phase 2
Miami, Florida, United States and 22 other locations
research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma...
Phase 2
Miami, Florida, United States
Approximately 40 participants with locally advanced or metastatic melanoma will be enrolled in 20 sites in the United States into 1 of the f...
Phase 2
Plantation, Florida, United States and 12 other locations
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
Miami, Florida, United States and 56 other locations
tolerability, PK and antitumor activities of IN10018 as monotherapy and in combination with cobimetinib in subjects with metastatic uveal melanoma...
Phase 1
Miami, Florida, United States and 7 other locations
attracting MDSCs. This first study will enroll participants with melanoma, as melanoma cancer has been shown to be able to attract ...
Phase 1
Miami, Florida, United States and 5 other locations
To evaluate the overall survival of HLA-A*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investiga...
Phase 2
Miami, Florida, United States and 55 other locations
antigen (HLA)-A*02:01 negative participants with metastatic uveal melanoma (MUM) who will be randomized to receive either IDE196 + crizotini...
Phase 2, Phase 3
Miami, Florida, United States and 62 other locations
patients with unresectable Stage III or IV melanoma. The contributions of BNT111 and cemiplimab will be delineated in single agent...
Phase 2
Miami, Florida, United States and 52 other locations
to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma...
Phase 3
Miami, Florida, United States and 171 other locations
Clinical trials
Research sites
Resources
Legal